Dr Cindy Varga discusses recent data on the FDA-approved agent teclistamab, a bispecific antibody for patients with relapsed/refractory multiple myeloma. Dr Jeremy Larsen reviews data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results